While the US can be confident in the safety of its globalized drug supply chain, thanks to the oversight of the US Food and Drug Administration, more could be done to promote US-based production of critical medicines, the Association for Accessible Medicines has urged the US Senate.
The AAM made its comments in testimony submitted to the US Senate Finance Committee at a hearing on “COVID-19 and...





